Skip to content

Glaucoma Eye Care

Active Private limited companyfounded 2023active for 2 yearsSnoy et d'Oppuerslaan 19, 3020 HerentKBO/BCE: BE 1003.663.552

Lifetime

3 annual accounts with figures on one time axis
peak of €276,481 in 2025
€276,481▲ 258%
lowest -€1,786 in 2023
€211,089▲ 247%
peak of €271,853 in 2025
€271,853▲ 347%
€48,402▲ 27.6%
Board1 name since 2023
1 director
Documentsfilings and deeds
20-03-2026133 days before the deadline
2025micro format
Gross margin from €77,276 to €276,481Result from €60,909 to €211,089Equity from €60,764 to €271,853Debts from €37,921 to €48,402Investments €3,426Cash from €28,056 to €152,883

Key points

from the 2025 annual accounts

Result

€211,089 ▲ 247%
€60,9002024€211,0002025

The result rose in 2025 from €60,909 to €211,089.

Turnover

≈ €420,000 estimated

The micro format states no turnover.

Investments

€3,426 9.4 times depreciation
20242025

Green is investment, beige is depreciation.

Liquidity

6.54 was 2.58 in 2024

Short-term debts rose from €37,921 to €48,402.

Position in the sector

€211,089

Higher net result than 89% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Glaucoma Eye Care has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Glaucoma Eye Care. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-12-2023
  • 120 sharesdeed of 22-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1003663552
Incorporation Founding capital of €2,500, 120 shares · Founded by · appointed as director · published on 22-12-2023 · Gazette deed
First establishment Snoy et d'Oppuerslaan 19, Herent
All 11 events

Comparable companies

same main activity, similar in size and age
Company
Glaucoma Eye Care Herent €320,255 €276,481 84.9% -
DENTHOMAX Grimbergen €335,798 €244,474 76.6% -
Dokter C.O. NCH Genk €321,138 €267,664 70.1% -
Labye Gynécologie-Obstétrique Visé €312,376 €288,085 99.2% -
ORTHO FARHAT Soignies €310,275 €293,888 83.4% -
Vinckier Olivier Tielt €337,534 €259,165 55.1% -
CABINET MEDICAL DR NICOLAS PEDINI Montigny-le-Tilleul €316,498 €249,830 79.1% -

These companies have the same main activity as Glaucoma Eye Care: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €310,000 and €338,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 20-12-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.353.995.9013020 Herent, since 20-12-2023
Financial year end
31 December
Peppol
Reachable since 18-06-2025
Company details

Annual accounts 2025

€320,255▲ 225%
Filing
Filed on 20-03-2026, 133 days before the end of the filing period
Financials

Insights on Glaucoma Eye Care

Glaucoma Eye Care files the micro format. That format states no turnover. The gross margin rose from -€1,786 in 2023 to €276,481 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Glaucoma Eye Care

What is the company number of Glaucoma Eye Care?
The company number of Glaucoma Eye Care is 1003.663.552. The VAT number is the same number with BE in front: BE 1003.663.552.
Where is Glaucoma Eye Care based?
The registered office is at Snoy et d'Oppuerslaan 19, 3020 Herent.Company details
What does Glaucoma Eye Care do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Glaucoma Eye Care?
Glaucoma Eye Care is a private limited company (BV).
When was Glaucoma Eye Care founded?
Glaucoma Eye Care was founded on 20-12-2023.
Is Glaucoma Eye Care still active?
Yes, Glaucoma Eye Care is an active enterprise in the KBO register.
What is the turnover of Glaucoma Eye Care?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €276,481 and 31 comparable companies (NACE 86220). It probably lies between €370,000 and €580,000.Financials
Is Glaucoma Eye Care profitable?
In financial year 2025, Glaucoma Eye Care made a profit of €211,089.
Where can I find the annual accounts of Glaucoma Eye Care?
Glaucoma Eye Care filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Glaucoma Eye Care due?
Glaucoma Eye Care must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.